0
0
Manipal Health Enterprises, widely known as Manipal Hospitals, delivered a strong financial performance in the first quarter of fiscal year 2027 (Q1 FY27), with revenue from operations reaching ₹3,091 crore.
Revenue increased 38.1% year-on-year (YoY), reflecting strong patient demand, higher volumes in complex medical procedures and the contribution from the company’s expanded hospital network. At the same time, EBITDA rose 26.4% YoY to ₹749 crore, highlighting continued operational growth despite investments associated with network expansion.
The results represent Manipal Hospitals’ first quarterly performance announcement following its listing in August 2026, making the numbers particularly significant for investors tracking India’s expanding hospital and healthcare sector.
Revenue Growth Reaches 38.1%
Manipal Hospitals generated ₹3,091 crore in revenue from operations during Q1 FY27, compared with ₹2,238 crore in the corresponding period of the previous year.
The company’s quarterly revenue also increased 7.2% sequentially from ₹2,882 crore in Q4 FY26. The growth demonstrates the company’s ability to absorb additional capacity while maintaining strong demand across its healthcare network.
One of the important contributors to the performance was the integration of Sahyadri Hospitals, which expanded Manipal’s presence and added capacity to its network.
EBITDA Climbs 26.4% to ₹749 Crore
EBITDA stood at ₹749 crore in Q1 FY27, representing a 26.4% YoY increase from ₹593 crore in Q1 FY26.
The EBITDA margin, however, stood at 24.2%, compared with 26.5% in the year-ago period. The decline in margin reflects the impact of the expanded network and the integration of acquired assets.
On an adjusted basis, excluding a ₹15 crore one-off gain in Q1 FY26, EBITDA growth was stronger at approximately 29.7% YoY.
This suggests that the underlying operating performance remained healthy despite the pressure on reported margins.
High-Acuity Specialties Drive Growth
A major factor behind Manipal Hospitals’ Q1 FY27 performance was the continued growth of high-acuity specialties.
Gross inpatient revenue from the company’s CONGO-R specialties increased 45% YoY, with these specialties accounting for approximately 65.4% of the specialty mix.
Oncology emerged as one of the strongest performers, with inpatient revenue increasing 62% YoY, while orthopedics recorded 49% YoY growth. These trends indicate increasing demand for complex and specialized medical treatment.
The increasing contribution from high-acuity specialties is strategically important because advanced clinical services can support stronger revenue generation per occupied bed and help hospitals improve their long-term profitability.
Hospital Occupancy Improves
Hospital occupancy reached 65% in Q1 FY27, up from 62.1% in the same quarter last year.
The improvement of nearly three percentage points indicates stronger utilization of Manipal Hospitals’ operational capacity. Average Revenue per Occupied Bed (ARPOB) also increased to approximately ₹71,500 per day, compared with ₹71,000 in Q1 FY26.
Higher occupancy combined with stable ARPOB provides an important foundation for future revenue growth as additional capacity is gradually absorbed.
Profit Performance Remains Mixed
While revenue and EBITDA recorded strong growth, reported profit after tax (PAT) was ₹243 crore, down approximately 4.2% YoY from ₹254 crore.
On a sequential basis, however, PAT increased by 30.5% from ₹187 crore in Q4 FY26.
The difference between strong EBITDA growth and relatively softer PAT performance highlights the effect of financing and other costs associated with the company’s expansion and acquisition strategy.
Reuters reported that Manipal Health’s adjusted quarterly profit increased by nearly 31%, reaching ₹332 crore, underscoring the strength of the company’s underlying operating performance.
SEO Analysis: What the Q1 FY27 Numbers Mean
From an investment and business perspective, Manipal Hospitals’ Q1 FY27 results present several positive signals.
1. Strong Top-Line Momentum
Revenue growth of 38.1% is significantly higher than the company’s historical growth trajectory and demonstrates strong demand for its healthcare services.
2. EBITDA Growth Remains Healthy
EBITDA growth of 26.4% shows that profitability at the operating level is expanding, although the slower EBITDA growth compared with revenue means investors will likely monitor margin recovery closely.
3. Specialty Care Is Becoming More Important
The strong performance of oncology, orthopedics and other high-acuity specialties supports Manipal Hospitals’ strategy of focusing on complex medical care.
4. Capacity Absorption Is Improving
The increase in occupancy to 65% suggests that the company is progressively utilizing its expanded hospital capacity. This could become an important earnings driver if occupancy continues to improve.
5. Integration Will Be a Key Factor
The integration of Sahyadri Hospitals is likely to remain an important factor for Manipal Hospitals in the coming quarters. Management’s ability to improve utilization and profitability at acquired facilities will be crucial to sustaining earnings growth.
Outlook for Manipal Hospitals
The Q1 FY27 results provide a positive starting point for Manipal Hospitals following its recent listing. Strong revenue growth, higher occupancy and robust demand for complex medical treatments indicate that the company continues to benefit from India’s growing healthcare requirements.
At the same time, the decline in EBITDA margin and softer reported PAT show that investors should look beyond revenue growth and track profitability, integration costs and the pace at which newer capacity reaches mature utilization levels.
If Manipal Hospitals can maintain strong patient volumes while improving the margins of recently integrated facilities, the company could have additional room to strengthen its earnings profile over the medium term.
Manipal Hospitals’ Q1 FY27 results demonstrate strong operational momentum. Revenue reached ₹3,091 crore, up 38.1% YoY, while EBITDA climbed 26.4% to ₹749 crore. Growth in oncology, orthopedics and other high-acuity specialties, combined with improving occupancy, supported the quarter’s performance.
The key challenge ahead will be converting strong revenue growth into higher margins and sustainable profit growth. For investors and industry observers, the next few quarters will therefore be important in determining whether Manipal Hospitals can translate its expanding network and specialty-care capabilities into stronger long-term profitability.
